<?xml version="1.0" encoding="UTF-8"?>
<bxExamples
	xmlns="http://bioxsd.org/example"
	xmlns:bx="http://bioxsd.org/BioXSD-0.3"
	xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
	xsi:schemaLocation="http://bioxsd.org/example http://bioxsd.org/bxExample(0.3).xsd"
>



<!-- This file contains a couple of examples of data represented in the BioXSD format, using the current beta version of the BioXSD schema

Content:
	GFF3 example
	UniProt/Swiss-Prot example
	GorIV prediction example
	set of sequences
	multiple sequence alignment example

-->



	<!--====================================================================-->



	<!-- GFF3 example

Toy example from http://www.sequenceontology.org/gff3.shtml:
 0		##gff-version	3
 1		##sequence-region		ctg123	1	1497228
 2		ctg123	.	gene					1000	9000	.	+	.	ID=gene00001;Name=EDEN
 3		ctg123	.	TF_binding_site 1000 1012	.	+	.	ID=tfbs00001;Parent=gene00001
 4		ctg123	.	mRNA				1050	9000	.	+	.	ID=mRNA00001;Parent=gene00001;Name=EDEN.1
 5		ctg123	.	mRNA				1050	9000	.	+	.	ID=mRNA00002;Parent=gene00001;Name=EDEN.2
 6		ctg123	.	mRNA				1300	9000	.	+	.	ID=mRNA00003;Parent=gene00001;Name=EDEN.3
 7		ctg123	.	exon					1300	1500	.	+	.	ID=exon00001;Parent=mRNA00003
 8		ctg123	.	exon					1050	1500	.	+	.	ID=exon00002;Parent=mRNA00001,mRNA00002
 9		ctg123	.	exon					3000	3902	.	+	.	ID=exon00003;Parent=mRNA00001,mRNA00003
10	ctg123	.	exon					5000	5500	.	+	.	ID=exon00004;Parent=mRNA00001,mRNA00002,mRNA00003
11	ctg123	.	exon					7000	9000	.	+	.	ID=exon00005;Parent=mRNA00001,mRNA00002,mRNA00003
12	ctg123	.	CDS					1201	1500	.	+	0	ID=cds00001;Parent=mRNA00001;Name=edenprotein.1
13	ctg123	.	CDS					3000	3902	.	+	0	ID=cds00001;Parent=mRNA00001;Name=edenprotein.1
14	ctg123	.	CDS					5000	5500	.	+	0	ID=cds00001;Parent=mRNA00001;Name=edenprotein.1
15	ctg123	.	CDS					7000	7600	.	+	0	ID=cds00001;Parent=mRNA00001;Name=edenprotein.1
16	ctg123	.	CDS					1201	1500	.	+	0	ID=cds00002;Parent=mRNA00002;Name=edenprotein.2
17	ctg123	.	CDS					5000	5500	.	+	0	ID=cds00002;Parent=mRNA00002;Name=edenprotein.2
18	ctg123	.	CDS					7000	7600	.	+	0	ID=cds00002;Parent=mRNA00002;Name=edenprotein.2
19	ctg123	.	CDS					3301	3902	.	+	0	ID=cds00003;Parent=mRNA00003;Name=edenprotein.3
20	ctg123	.	CDS					5000	5500	.	+	1	ID=cds00003;Parent=mRNA00003;Name=edenprotein.3
21	ctg123	.	CDS					7000	7600	.	+	2	ID=cds00003;Parent=mRNA00003;Name=edenprotein.3
22	ctg123	.	CDS					3391	3902	.	+	0	ID=cds00004;Parent=mRNA00003;Name=edenprotein.4
23	ctg123	.	CDS					5000	5500	.	+	1	ID=cds00004;Parent=mRNA00003;Name=edenprotein.4
24	ctg123	.	CDS					7000	7600	.	+	2	ID=cds00004;Parent=mRNA00003;Name=edenprotein.4 

From this example, missing in the current beta version are: frames, custom names of instances; to optimise: evidences

	-->
	<exampleFromGFF3>
		<bx:sequenceReference><!--Computer-readable reference-->
			<bx:accession>ctg123</bx:accession>
			<bx:databaseName>just an example</bx:databaseName>
		</bx:sequenceReference>
		<bx:blockWithReferences>
			<bx:feature>
				<bx:featureType>
					<bx:name>gene</bx:name><!--Human-readable name-->
					<bx:vocabularyTerm><!--Computer-readable name-->
						<bx:accession>SO:0000704</bx:accession>
						<bx:databaseName>Sequence Ontology</bx:databaseName>
						<bx:databaseUri>http://www.sequenceontology.org</bx:databaseUri>
					</bx:vocabularyTerm>
				</bx:featureType>
				<bx:occurence localId="gene00001">
					<bx:position>
						<bx:segment>
							<bx:start>1000</bx:start>
							<bx:end>9000</bx:end>
							<bx:strand>+</bx:strand>
						</bx:segment>
					</bx:position>
					<bx:evidence>
						<bx:experimental>
							<bx:dbReference><!--Computer-readable reference to additional data-->
								<bx:accession>ctg123</bx:accession>
								<bx:databaseName>just an example</bx:databaseName>
							</bx:dbReference>
						</bx:experimental>
					</bx:evidence>
				</bx:occurence>
			</bx:feature>
			<bx:feature>
				<bx:featureType>
					<bx:name>transcription factor binding site</bx:name>
				</bx:featureType>
				<bx:occurence localId="tfbs00001">
					<bx:position>
						<bx:segment>
							<bx:start>1000</bx:start>
							<bx:end>1012</bx:end>
							<bx:strand>+</bx:strand>
						</bx:segment>
					</bx:position>
					<bx:evidence>
						<bx:predicted>
							<bx:method>just an example</bx:method>
							<bx:finding>Present</bx:finding>
						</bx:predicted>
					</bx:evidence>
					<bx:evidence>
						<bx:predicted>
							<bx:method>just an example 2</bx:method>
							<bx:finding>Putative</bx:finding>
						</bx:predicted>
					</bx:evidence>
					<bx:partOf>gene00001</bx:partOf>
				</bx:occurence>
			</bx:feature>
			<bx:feature>
				<bx:featureType>
					<bx:name>mRNA</bx:name>
					<bx:vocabularyTerm>
						<bx:accession>SO:0000234</bx:accession>
						<bx:databaseName>OBO</bx:databaseName>
						<bx:databaseUri>http://obofoundry.org</bx:databaseUri>
					</bx:vocabularyTerm>
				</bx:featureType>
				<bx:occurence localId="mRNA00001">
					<bx:position>
						<bx:segment>
							<bx:start>1050</bx:start>
							<bx:end>9000</bx:end>
							<bx:strand>+</bx:strand>
						</bx:segment>
					</bx:position>
					<bx:evidence>
						<bx:experimental>
							<bx:dbReference>
								<bx:accession>ctg123</bx:accession>
								<bx:databaseName>just an example</bx:databaseName>
							</bx:dbReference>
						</bx:experimental>
					</bx:evidence>
					<bx:partOf>gene00001</bx:partOf>
				</bx:occurence>
				<bx:occurence localId="mRNA00002">
					<bx:position>
						<bx:segment>
							<bx:start>1050</bx:start>
							<bx:end>9000</bx:end>
							<bx:strand>+</bx:strand>
						</bx:segment>
					</bx:position>
					<bx:evidence>
						<bx:experimental>
							<bx:dbReference>
								<bx:accession>ctg123</bx:accession>
								<bx:databaseName>just an example</bx:databaseName>
							</bx:dbReference>
						</bx:experimental>
					</bx:evidence>
					<bx:partOf>gene00001</bx:partOf>
				</bx:occurence>
				<bx:occurence localId="mRNA00003">
					<bx:position>
						<bx:segment>
							<bx:start>1300</bx:start>
							<bx:end>9000</bx:end>
							<bx:strand>+</bx:strand>
						</bx:segment>
					</bx:position>
					<bx:evidence>
						<bx:experimental>
							<bx:dbReference>
								<bx:accession>ctg123</bx:accession>
								<bx:databaseName>just an example</bx:databaseName>
							</bx:dbReference>
						</bx:experimental>
					</bx:evidence>
					<bx:partOf>gene00001</bx:partOf>
				</bx:occurence>
			</bx:feature>
			<bx:feature>
				<bx:featureType>
					<bx:name>exon</bx:name>
					<bx:vocabularyTerm>
						<bx:accession>SO:0000147</bx:accession>
					</bx:vocabularyTerm>
				</bx:featureType>
				<bx:occurence localId="exon00001">
					<bx:position>
						<bx:segment>
							<bx:start>1300</bx:start>
							<bx:end>1500</bx:end>
							<bx:strand>+</bx:strand>
						</bx:segment>
					</bx:position>
					<bx:evidence>
						<bx:experimental>
							<bx:dbReference>
								<bx:accession>ctg123</bx:accession>
								<bx:databaseName>just an example</bx:databaseName>
							</bx:dbReference>
						</bx:experimental>
					</bx:evidence>
					<bx:partOf>mRNA00003</bx:partOf>
				</bx:occurence>
				<bx:occurence localId="exon00002">
					<bx:position>
						<bx:segment>
							<bx:start>1050</bx:start>
							<bx:end>1500</bx:end>
							<bx:strand>+</bx:strand>
						</bx:segment>
					</bx:position>
					<bx:evidence>
						<bx:experimental>
							<bx:dbReference>
								<bx:accession>ctg123</bx:accession>
								<bx:databaseName>just an example</bx:databaseName>
							</bx:dbReference>
						</bx:experimental>
					</bx:evidence>
					<bx:partOf>mRNA00001</bx:partOf>
					<bx:partOf>mRNA00002</bx:partOf>
				</bx:occurence>
				<bx:occurence localId="exon00003">
					<bx:position>
						<bx:segment>
							<bx:start>3000</bx:start>
							<bx:end>3902</bx:end>
							<bx:strand>+</bx:strand>
						</bx:segment>
					</bx:position>
					<bx:evidence>
						<bx:experimental>
							<bx:dbReference>
								<bx:accession>ctg123</bx:accession>
								<bx:databaseName>just an example</bx:databaseName>
							</bx:dbReference>
						</bx:experimental>
					</bx:evidence>
					<bx:partOf>mRNA00001</bx:partOf>
					<bx:partOf>mRNA00003</bx:partOf>
				</bx:occurence>
				<bx:occurence localId="exon00004">
					<bx:position>
						<bx:segment>
							<bx:start>5000</bx:start>
							<bx:end>5500</bx:end>
							<bx:strand>+</bx:strand>
						</bx:segment>
					</bx:position>
					<bx:evidence>
						<bx:experimental>
							<bx:dbReference>
								<bx:accession>ctg123</bx:accession>
								<bx:databaseName>just an example</bx:databaseName>
							</bx:dbReference>
						</bx:experimental>
					</bx:evidence>
					<bx:partOf>mRNA00001</bx:partOf>
					<bx:partOf>mRNA00002</bx:partOf>
					<bx:partOf>mRNA00003</bx:partOf>
				</bx:occurence>
				<bx:occurence localId="exon00005">
					<bx:position>
						<bx:segment>
							<bx:start>7000</bx:start>
							<bx:end>9000</bx:end>
							<bx:strand>+</bx:strand>
						</bx:segment>
					</bx:position>
					<bx:evidence>
						<bx:experimental>
							<bx:dbReference>
								<bx:accession>ctg123</bx:accession>
								<bx:databaseName>just an example</bx:databaseName>
							</bx:dbReference>
						</bx:experimental>
					</bx:evidence>
					<bx:partOf>mRNA00001</bx:partOf>
					<bx:partOf>mRNA00002</bx:partOf>
					<bx:partOf>mRNA00003</bx:partOf>
				</bx:occurence>
			</bx:feature>
			<bx:feature>
				<bx:featureType>
					<bx:name>CDS</bx:name>
					<bx:vocabularyTerm>
						<bx:accession>SO:0000316</bx:accession>
						<bx:databaseName>Sequence Ontology</bx:databaseName>
					</bx:vocabularyTerm>
				</bx:featureType>
				<bx:occurence localId="cds00001">
					<bx:position>
						<bx:segment>
							<bx:start>1201</bx:start>
							<bx:end>1500</bx:end>
							<bx:strand>+</bx:strand>
						</bx:segment>
						<bx:segment>
							<bx:start>3000</bx:start>
							<bx:end>3902</bx:end>
							<bx:strand>+</bx:strand>
						</bx:segment>
						<bx:segment>
							<bx:start>5000</bx:start>
							<bx:end>5500</bx:end>
							<bx:strand>+</bx:strand>
						</bx:segment>
						<bx:segment>
							<bx:start>7000</bx:start>
							<bx:end>7600</bx:end>
							<bx:strand>+</bx:strand>
						</bx:segment>
					</bx:position>
					<bx:evidence>
						<bx:experimental>
							<bx:dbReference>
								<bx:accession>ctg123</bx:accession>
								<bx:databaseName>just an example</bx:databaseName>
							</bx:dbReference>
						</bx:experimental>
					</bx:evidence>
					<bx:partOf>mRNA00001</bx:partOf>
				</bx:occurence>
				<bx:occurence localId="cds00002">
					<bx:position>
						<bx:segment>
							<bx:start>1201</bx:start>
							<bx:end>1500</bx:end>
							<bx:strand>+</bx:strand>
						</bx:segment>
						<bx:segment>
							<bx:start>5000</bx:start>
							<bx:end>5500</bx:end>
							<bx:strand>+</bx:strand>
						</bx:segment>
						<bx:segment>
							<bx:start>7000</bx:start>
							<bx:end>7600</bx:end>
							<bx:strand>+</bx:strand>
						</bx:segment>
					</bx:position>
					<bx:evidence>
						<bx:experimental>
							<bx:dbReference>
								<bx:accession>ctg123</bx:accession>
								<bx:databaseName>just an example</bx:databaseName>
							</bx:dbReference>
						</bx:experimental>
					</bx:evidence>
					<bx:partOf>mRNA00002</bx:partOf>
				</bx:occurence>
				<bx:occurence localId="cds00003">
					<bx:position>
						<bx:segment>
							<bx:start>3301</bx:start>
							<bx:end>3902</bx:end>
							<bx:strand>+</bx:strand>
						</bx:segment>
						<bx:segment>
							<bx:start>5000</bx:start>
							<bx:end>5500</bx:end>
							<bx:strand>+</bx:strand>
						</bx:segment>
						<bx:segment>
							<bx:start>7000</bx:start>
							<bx:end>7600</bx:end>
							<bx:strand>+</bx:strand>
						</bx:segment>
					</bx:position>
					<bx:evidence>
						<bx:experimental>
							<bx:dbReference>
								<bx:accession>ctg123</bx:accession>
								<bx:databaseName>just an example</bx:databaseName>
							</bx:dbReference>
						</bx:experimental>
					</bx:evidence>
					<bx:partOf>mRNA00003</bx:partOf>
				</bx:occurence>
				<bx:occurence localId="cds00004">
					<bx:position>
						<bx:segment>
							<bx:start>3391</bx:start>
							<bx:end>3902</bx:end>
							<bx:strand>+</bx:strand>
						</bx:segment>
						<bx:segment>
							<bx:start>5000</bx:start>
							<bx:end>5500</bx:end>
							<bx:strand>+</bx:strand>
						</bx:segment>
						<bx:segment>
							<bx:start>7000</bx:start>
							<bx:end>7600</bx:end>
							<bx:strand>+</bx:strand>
						</bx:segment>
					</bx:position>
					<bx:evidence>
						<bx:experimental>
							<bx:dbReference>
								<bx:accession>ctg123</bx:accession>
								<bx:databaseName>just an example</bx:databaseName>
							</bx:dbReference>
						</bx:experimental>
					</bx:evidence>
					<bx:partOf>mRNA00003</bx:partOf>
				</bx:occurence>
			</bx:feature>
		</bx:blockWithReferences>
	</exampleFromGFF3>


	
	<!--====================================================================-->



	<!-- UniProt/Swiss-Prot example

So far, the BioXSD-formatted example contains only the secondary-structure annotation. More features will be added to this example, as most of the UniProt feature data can already be modelled in the current beta version.

ID   P53_HUMAN               Reviewed;         393 AA.
AC   P04637; Q15086; Q15087; Q15088; Q16535; Q16807; Q16808; Q16809;
AC   Q16810; Q16811; Q16848; Q86UG1; Q8J016; Q99659; Q9BTM4; Q9HAQ8;
AC   Q9NP68; Q9NPJ2; Q9NZD0; Q9UBI2; Q9UQ61;
DT   13-AUG-1987, integrated into UniProtKB/Swiss-Prot.
DT   22-JUL-2008, sequence version 3.
DT   22-SEP-2009, entry version 164.
DE   RecName: Full=Cellular tumor antigen p53;
DE   AltName: Full=Tumor suppressor p53;
DE   AltName: Full=Phosphoprotein p53;
DE   AltName: Full=Antigen NY-CO-13;
GN   Name=TP53; Synonyms=P53;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   MEDLINE=85230577; PubMed=4006916;
RA   Zakut-Houri R., Bienz-Tadmor B., Givol D., Oren M.;
RT   "Human p53 cellular tumor antigen: cDNA sequence and expression in COS
RT   cells.";
RL   EMBO J. 4:1251-1255(1985).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA], AND VARIANT GLY-76.
RX   MEDLINE=87064416; PubMed=2946935;
RA   Lamb P., Crawford L.;
RT   "Characterization of the human p53 gene.";
RL   Mol. Cell. Biol. 6:1379-1385(1986).
...
RN   [118]
RP   VARIANTS PRO-110; VAL-113; VAL-138; CYS-163; HIS-163; THR-195;
RP   MET-216; ALA-241; MET-249; SER-251; TYR-259 AND CYS-273.
RX   PubMed=17224074; DOI=10.1186/bcr1637;
RA   Chanock S.J., Burdett L., Yeager M., Llaca V., Langeroed A.,
RA   Presswalla S., Kaaresen R., Strausberg R.L., Gerhard D.S.,
RA   Kristensen V., Perou C.M., Boerresen-Dale A.-L.;
RT   "Somatic sequence alterations in twenty-one genes selected by
RT   expression profile analysis of breast carcinomas.";
RL   Breast Cancer Res. 9:R5-R5(2007).
RN   [119]
RP   VARIANTS.
RX   PubMed=17311302; DOI=10.1002/humu.20495;
RA   Petitjean A., Mathe E., Kato S., Ishioka C., Tavtigian S.V.,
RA   Hainaut P., Olivier M.;
RT   "Impact of mutant p53 functional properties on TP53 mutation patterns
RT   and tumor phenotype: lessons from recent developments in the IARC TP53
RT   database.";
RL   Hum. Mutat. 28:622-629(2007).
CC   -!- FUNCTION: Acts as a tumor suppressor in many tumor types; induces
CC       growth arrest or apoptosis depending on the physiological
CC       circumstances and cell type. Involved in cell cycle regulation as
CC       a trans-activator that acts to negatively regulate cell division
CC       by controlling a set of genes required for this process. One of
CC       the activated genes is an inhibitor of cyclin-dependent kinases.
CC       Apoptosis induction seems to be mediated either by stimulation of
CC       BAX and FAS antigen expression, or by repression of Bcl-2
CC       expression. Implicated in Notch signaling cross-over.
CC   -!- COFACTOR: Binds 1 zinc ion per subunit.
CC   -!- SUBUNIT: Interacts with AXIN1. Probably part of a complex
CC       consisting of TP53, HIPK2 and AXIN1 (By similarity). Binds DNA as
CC       a homotetramer. Interacts with histone acetyltransferases EP300
CC       and methyltransferases HRMT1L2 and CARM1, and recruits them to
CC       promoters. In vitro, the interaction of TP53 with cancer-
CC       associated/HPV (E6) viral proteins leads to ubiquitination and
CC       degradation of TP53 giving a possible model for cell growth
CC       regulation. This complex formation requires an additional factor,
CC       E6-AP, which stably associates with TP53 in the presence of E6.
CC       Interacts (via C-terminus) with TAF1; when TAF1 is part of the
CC       TFIID complex. Interacts with ING4; this interaction may be
CC       indirect. Found in a complex with CABLES1 and TP73. Interacts with
CC       HIPK1, HIPK2, and P53DINP1. Interacts with WWOX. May interact with
CC       HCV core protein. Interacts with USP7 and SYVN1. Interacts with
CC       HSP90AB1. Interacts with CHD8; leading to recruit histone H1 and
CC       prevent transactivation activity (By similarity). Interacts with
CC       ARMC10, BANP, CDKN2AIP and E4F1. Interacts with YWHAZ; the
CC       interaction enhances TP53 transcriptional activity.
CC       Phosphorylation of YWHAZ on 'Ser-58' inhibits this interaction.
CC       Interacts (via DNA-binding domain) with MAML1 (via N-terminus).
CC       Interacts with MKRN1. Directly interacts with FBXO42; leading to
CC       ubiquination and degradation of TP53.
CC   -!- INTERACTION:
CC       P03070:- (xeno); NbExp=3; IntAct=EBI-366083, EBI-617698;
CC       Q9PST7:- (xeno); NbExp=2; IntAct=EBI-366083, EBI-1782562;
CC       Q13535:ATR; NbExp=1; IntAct=EBI-366083, EBI-968983;
CC       Q99728:BARD1; NbExp=1; IntAct=EBI-366083, EBI-473181;
CC       O70445:Bard1 (xeno); NbExp=1; IntAct=EBI-366083, EBI-1790207;
CC       Q07817-1:BCL2L1; NbExp=2; IntAct=EBI-366083, EBI-287195;
CC       P51813:BMX; NbExp=1; IntAct=EBI-366083, EBI-696657;
CC       Q9BX70:BTBD2; NbExp=1; IntAct=EBI-366083, EBI-710091;
CC       Q8TDN4:CABLES1; NbExp=1; IntAct=EBI-366083, EBI-604615;
CC       Q9ESJ1:Cables1 (xeno); NbExp=1; IntAct=EBI-366083, EBI-604411;
CC       P17676:CEBPB; NbExp=3; IntAct=EBI-366083, EBI-969696;
CC       Q92793:CREBBP; NbExp=3; IntAct=EBI-366083, EBI-81215;
CC       P45481:Crebbp (xeno); NbExp=2; IntAct=EBI-366083, EBI-296306;
CC       P55060:CSE1L; NbExp=4; IntAct=EBI-366083, EBI-286709;
CC       Q14999:CUL7; NbExp=1; IntAct=EBI-366083, EBI-308606;
CC       Q8IWT3:CUL9; NbExp=1; IntAct=EBI-366083, EBI-311123;
CC       Q9UER7:DAXX; NbExp=3; IntAct=EBI-366083, EBI-77321;
CC       Q09472:EP300; NbExp=3; IntAct=EBI-366083, EBI-447295;
CC       Q86XK2:FBXO11; NbExp=3; IntAct=EBI-366083, EBI-1047804;
CC       Q9BVP2:GNL3; NbExp=1; IntAct=EBI-366083, EBI-641642;
CC       Q13547:HDAC1; NbExp=1; IntAct=EBI-366083, EBI-301834;
CC       Q86Z02:HIPK1; NbExp=1; IntAct=EBI-366083, EBI-692891;
CC       P09429:HMGB1; NbExp=1; IntAct=EBI-366083, EBI-389432;
CC       Q9BUJ2:HNRNPUL1; NbExp=6; IntAct=EBI-366083, EBI-1018153;
CC       P42858:HTT; NbExp=2; IntAct=EBI-366083, EBI-466029;
CC       Q7Z6Z7:HUWE1; NbExp=2; IntAct=EBI-366083, EBI-625934;
CC       Q8N9B5:JMY; NbExp=1; IntAct=EBI-366083, EBI-866435;
CC       Q92993:KAT5; NbExp=1; IntAct=EBI-366083, EBI-399080;
CC       Q15759:MAPK11; NbExp=1; IntAct=EBI-366083, EBI-298304;
CC       Q15759-2:MAPK11; NbExp=1; IntAct=EBI-366083, EBI-303766;
CC       Q8IW41:MAPKAPK5; NbExp=1; IntAct=EBI-366083, EBI-1201460;
CC       Q00987:MDM2; NbExp=7; IntAct=EBI-366083, EBI-389668;
CC       P56273:mdm2 (xeno); NbExp=1; IntAct=EBI-366083, EBI-541233;
CC       O15151:MDM4; NbExp=2; IntAct=EBI-366083, EBI-398437;
CC       P23511:NFYA; NbExp=2; IntAct=EBI-366083, EBI-389739;
CC       P06748:NPM1; NbExp=3; IntAct=EBI-366083, EBI-78579;
CC       P06748-1:NPM1; NbExp=1; IntAct=EBI-366083, EBI-354150;
CC       P09874:PARP1; NbExp=1; IntAct=EBI-366083, EBI-355676;
CC       Q96KB5:PBK; NbExp=2; IntAct=EBI-366083, EBI-536853;
CC       O75925:PIAS1; NbExp=1; IntAct=EBI-366083, EBI-629434;
CC       Q8N2W9:PIAS4; NbExp=1; IntAct=EBI-366083, EBI-473160;
CC       P29590:PML; NbExp=1; IntAct=EBI-366083, EBI-295890;
CC       P36873-1:PPP1CC; NbExp=2; IntAct=EBI-366083, EBI-356289;
CC       Q05397:PTK2; NbExp=6; IntAct=EBI-366083, EBI-702142;
CC       Q06609:RAD51; NbExp=1; IntAct=EBI-366083, EBI-297202;
CC       P27694:RPA1; NbExp=1; IntAct=EBI-366083, EBI-621389;
CC       P62988:RPS27A; NbExp=1; IntAct=EBI-366083, EBI-413034;
CC       P62991:Rps27a (xeno); NbExp=1; IntAct=EBI-366083, EBI-413074;
CC       Q8WTS6:SETD7; NbExp=3; IntAct=EBI-366083, EBI-1268586;
CC       Q96ST3:SIN3A; NbExp=2; IntAct=EBI-366083, EBI-347218;
CC       P20226:TBP; NbExp=1; IntAct=EBI-366083, EBI-355371;
CC       Q13625:TP53BP2; NbExp=1; IntAct=EBI-366083, EBI-77642;
CC       Q9H3D4:TP63; NbExp=1; IntAct=EBI-366083, EBI-2337775;
CC       O88898:Tp63 (xeno); NbExp=1; IntAct=EBI-366083, EBI-2338025;
CC       Q05086:UBE3A; NbExp=1; IntAct=EBI-366083, EBI-954357;
CC       Q93009:USP7; NbExp=4; IntAct=EBI-366083, EBI-302474;
CC       Q14191:WRN; NbExp=2; IntAct=EBI-366083, EBI-368417;
CC       P12956:XRCC6; NbExp=1; IntAct=EBI-366083, EBI-353208;
CC       Q96PM9:ZNF385A; NbExp=1; IntAct=EBI-366083, EBI-1539778;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm. Nucleus. Endoplasmic reticulum.
CC       Note=Interaction with BANP promotes nuclear localization.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=P04637-1; Sequence=Displayed;
CC       Name=2; Synonyms=I9RET;
CC         IsoId=P04637-2; Sequence=VSP_006535, VSP_006536;
CC         Note=Seems to be non-functional. Expressed in quiescent
CC         lymphocytes;
CC   -!- DOMAIN: The nuclear export signal acts as a transcriptional
CC       repression domain.
CC   -!- PTM: Acetylated. Acetylation of Lys-382 by CREBBP enhances
CC       transcriptional activity. Deacetylation of Lys-382 by SIRT1
CC       impairs its ability to induce proapoptotic program and modulate
CC       cell senescence.
CC   -!- PTM: Phosphorylation on Ser residues mediates transcriptional
CC       activation. Phosphorylated by HIPK1 (By similarity).
CC       Phosphorylation at Ser-9 by HIPK4 increases repression activity on
CC       BIRC5 promoter. Phosphorylated on Thr-18 by VRK1, which may
CC       prevent the interaction with MDM2. Phosphorylated on Thr-55 by
CC       TAF1, which promotes MDM2-mediated degradation. Phosphorylated on
CC       Ser-46 by HIPK2 upon UV irradiation. Phosphorylation on Ser-46 is
CC       required for acetylation by CREBBP. Phosphorylated on Ser-392
CC       following UV but not gamma irradiation. Phosphorylated upon DNA
CC       damage, probably by ATM or ATR. Phosphorylated on Ser-15 upon
CC       ultraviolet irradiation; which is enhanced by interaction with
CC       BANP.
CC   -!- PTM: Dephosphorylated by PP2A. SV40 small T antigen inhibits the
CC       dephosphorylation by the AC form of PP2A.
CC   -!- PTM: May be O-glycosylated in the C-terminal basic region. Studied
CC       in EB-1 cell line.
CC   -!- PTM: Ubiquitinated by SYVN1, which leads to proteasomal
CC       degradation. Ubiquitinated by MKRN1 at Lys-291 and Lys-292, which
CC       leads to proteasomal degradation.
CC   -!- PTM: Monomethylated at Lys-372 by SETD7, leading to stabilization
CC       and increased transcriptional activation. Monomethylated at Lys-
CC       370 by SMYD2, leading to decreased DNA-binding activity and
CC       subsequent transcriptional regulation activity. Lys-372
CC       monomethylation prevents interaction with SMYD2 and subsequent
CC       monomethylation at Lys-370.
CC   -!- PTM: Sumoylated by SUMO1.
CC   -!- PTM: Demethylation of di-methylated Lys-370 by KDM1/LSD1 prevents
CC       interaction with TP53BP1 and represses TP53-mediated
CC       transcriptional activation.
CC   -!- DISEASE: TP53 is found in increased amounts in a wide variety of
CC       transformed cells. TP53 is frequently mutated or inactivated in
CC       about 60% of cancers.
CC   -!- DISEASE: Defects in TP53 are involved in esophageal squamous cell
CC       carcinoma (ESCC) [MIM:133239]. ESCC is a tumor of the esophagus.
CC   -!- DISEASE: Defects in TP53 are a cause of Li-Fraumeni syndrome (LFS)
CC       [MIM:151623]. LFS is an autosomal dominant familial cancer
CC       syndrome that in its classic form is defined by the existence of a
CC       proband affected by a sarcoma before 45 years with a first degree
CC       relative affected by any tumor before 45 years and another first
CC       degree relative with any tumor before 45 years or a sarcoma at any
CC       age. Other clinical definitions for LFS have been proposed
CC       (PubMed:8118819 and PubMed:8718514) and called Li-Fraumeni like
CC       syndrome (LFL). In these families affected relatives develop a
CC       diverse set of malignancies at unusually early ages. Four types of
CC       cancers account for 80% of tumors occurring in TP53 germline
CC       mutation carriers: breast cancers, soft tissue and bone sarcomas,
CC       brain tumors (astrocytomas) and adrenocortical carcinomas. Less
CC       frequent tumors include choroid plexus carcinoma or papilloma
CC       before the age of 15, rhabdomyosarcoma before the age of 5,
CC       leukemia, Wilms tumor, malignant phyllodes tumor, colorectal and
CC       gastric cancers.
CC   -!- DISEASE: Defects in TP53 may be associated with nasopharyngeal
CC       carcinoma [MIM:161550]; also known as nasopharyngeal cancer.
CC   -!- DISEASE: Defects in TP53 are found in Barrett metaplasia; also
CC       known as Barrett esophagus. It is a condition in which the
CC       normally stratified squamous epithelium of the lower esophagus is
CC       replaced by a metaplastic columnar epithelium. The condition
CC       develops as a complication in approximately 10% of patients with
CC       chronic gastroesophageal reflux disease and predisposes to the
CC       development of esophageal adenocarcinoma.
CC   -!- DISEASE: Defects in TP53 are involved in head and neck squamous
CC       cell carcinomas (HNSCC) [MIM:275355].
CC   -!- DISEASE: Defects in TP53 are involved in oral squamous cell
CC       carcinoma (OSCC). Cigarette smoke is a prime mutagenic agent in
CC       cancer of the aerodigestive tract.
CC   -!- DISEASE: Defects in TP53 are a cause of lung cancer [MIM:211980].
CC   -!- DISEASE: Defects in TP53 are a cause of choroid plexus papilloma
CC       [MIM:260500]. Choroid plexus papilloma is a slow-growing benign
CC       tumor of the choroid plexus that often invades the leptomeninges.
CC       In children it is usually in a lateral ventricle but in adults it
CC       is more often in the fourth ventricle. Hydrocephalus is common,
CC       either from obstruction or from tumor secretion of cerebrospinal
CC       fluid. If it undergoes malignant transformation it is called a
CC       choroid plexus carcinoma. Primary choroid plexus tumors are rare
CC       and usually occur in early childhood.
CC   -!- DISEASE: Defects in TP53 are a cause of one form of hereditary
CC       adrenocortical carcinoma (ADCC) [MIM:202300]. ADCC is a rare
CC       childhood tumor, representing about 0.4% of childhood tumors, with
CC       a high incidence of associated tumors. ADCC occurs with increased
CC       frequency in patients with the Beckwith-Wiedemann syndrome
CC       [MIM:130650] and is a component tumor in Li-Fraumeni syndrome
CC       [MIM:151623].
CC   -!- SIMILARITY: Belongs to the p53 family.
CC   -!- WEB RESOURCE: Name=IARC TP53 mutation database; Note=Somatic and
CC       germline TP53 mutations in human cancers;
CC       URL="http://www-p53.iarc.fr/";
CC   -!- WEB RESOURCE: Name=p53 web site at the Institut Curie;
CC       URL="http://p53.free.fr/";
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology
CC       and Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/P53ID88.html";
CC   -!- WEB RESOURCE: Name=GeneReviews;
CC       URL="http://www.genetests.org/query?gene=TP53";
CC   -!- WEB RESOURCE: Name=NIEHS-SNPs;
CC       URL="http://egp.gs.washington.edu/data/tp53/";
CC   -!- WEB RESOURCE: Name=SHMPD; Note=The Singapore human mutation and
CC       polymorphism database;
CC       URL="http://shmpd.bii.a-star.edu.sg/gene.php?genestart=A&genename=TP53";
CC   -!- WEB RESOURCE: Name=Wikipedia; Note=P53 entry;
CC       URL="http://en.wikipedia.org/wiki/P53";
CC   -
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -
DR   EMBL; X02469; CAA26306.1; -; mRNA.
DR   EMBL; M13121; AAA59987.1; -; Genomic_DNA.
DR   EMBL; M13112; AAA59987.1; JOINED; Genomic_DNA.
DR   EMBL; M13113; AAA59987.1; JOINED; Genomic_DNA.
DR   EMBL; M13114; AAA59987.1; JOINED; Genomic_DNA.
DR   EMBL; M13115; AAA59987.1; JOINED; Genomic_DNA.
DR   EMBL; M13116; AAA59987.1; JOINED; Genomic_DNA.
DR   EMBL; M13117; AAA59987.1; JOINED; Genomic_DNA.
DR   EMBL; M13118; AAA59987.1; JOINED; Genomic_DNA.
DR   EMBL; M13119; AAA59987.1; JOINED; Genomic_DNA.
DR   EMBL; M13120; AAA59987.1; JOINED; Genomic_DNA.
DR   EMBL; K03199; AAA59989.1; -; mRNA.
DR   EMBL; M14694; AAA61211.1; -; mRNA.
DR   EMBL; M14695; AAA61212.1; -; mRNA.
DR   EMBL; M22898; AAA59988.1; -; Genomic_DNA.
DR   EMBL; M22882; AAA59988.1; JOINED; Genomic_DNA.
DR   EMBL; M22883; AAA59988.1; JOINED; Genomic_DNA.
DR   EMBL; M22884; AAA59988.1; JOINED; Genomic_DNA.
DR   EMBL; M22887; AAA59988.1; JOINED; Genomic_DNA.
DR   EMBL; M22888; AAA59988.1; JOINED; Genomic_DNA.
DR   EMBL; M22894; AAA59988.1; JOINED; Genomic_DNA.
DR   EMBL; M22895; AAA59988.1; JOINED; Genomic_DNA.
DR   EMBL; M22896; AAA59988.1; JOINED; Genomic_DNA.
DR   EMBL; M22897; AAA59988.1; JOINED; Genomic_DNA.
DR   EMBL; X01405; CAA25652.1; -; mRNA.
DR   EMBL; X60011; CAA42626.1; -; mRNA.
DR   EMBL; X60012; CAA42627.1; ALT_TERM; mRNA.
DR   EMBL; X60013; CAA42628.1; -; mRNA.
DR   EMBL; X60014; CAA42629.1; -; mRNA.
DR   EMBL; X60015; CAA42630.1; -; mRNA.
DR   EMBL; X60016; CAA42631.1; -; mRNA.
DR   EMBL; X60017; CAA42632.1; -; mRNA.
DR   EMBL; X60018; CAA42633.1; -; mRNA.
DR   EMBL; X60019; CAA42634.1; -; mRNA.
DR   EMBL; X60020; CAA42635.1; -; mRNA.
DR   EMBL; AF135121; AAD28535.1; -; Genomic_DNA.
DR   EMBL; AF135120; AAD28535.1; JOINED; Genomic_DNA.
DR   EMBL; AF307851; AAG28785.1; -; mRNA.
DR   EMBL; X54156; CAA38095.1; -; Genomic_DNA.
DR   EMBL; U94788; AAC12971.1; -; Genomic_DNA.
DR   EMBL; AF136271; AAD28628.1; -; Genomic_DNA.
DR   EMBL; AF136270; AAD28628.1; JOINED; Genomic_DNA.
DR   EMBL; AB082923; BAC16799.1; -; mRNA.
DR   EMBL; AY838896; AAV80424.1; -; Genomic_DNA.
DR   EMBL; BC003596; AAH03596.1; -; mRNA.
DR   EMBL; AY429684; AAR10356.1; -; mRNA.
DR   EMBL; AY390341; AAQ90158.1; -; Genomic_DNA.
DR   EMBL; AY359814; AAR13239.1; -; Genomic_DNA.
DR   EMBL; U63714; AAB39322.1; -; Genomic_DNA.
DR   EMBL; AF209136; AAF36362.1; -; Genomic_DNA.
DR   EMBL; AF209128; AAF36354.1; -; Genomic_DNA.
DR   EMBL; AF209129; AAF36355.1; -; Genomic_DNA.
DR   EMBL; AF209130; AAF36356.1; -; Genomic_DNA.
DR   EMBL; AF209131; AAF36357.1; -; Genomic_DNA.
DR   EMBL; AF209132; AAF36358.1; -; Genomic_DNA.
DR   EMBL; AF209133; AAF36359.1; -; Genomic_DNA.
DR   EMBL; AF209134; AAF36360.1; -; Genomic_DNA.
DR   EMBL; AF209135; AAF36361.1; -; Genomic_DNA.
DR   EMBL; AF209148; AAF36374.1; -; Genomic_DNA.
DR   EMBL; AF209149; AAF36375.1; -; Genomic_DNA.
DR   EMBL; AF209150; AAF36376.1; -; Genomic_DNA.
DR   EMBL; AF209151; AAF36377.1; -; Genomic_DNA.
DR   EMBL; AF209152; AAF36378.1; -; Genomic_DNA.
DR   EMBL; AF209153; AAF36379.1; -; Genomic_DNA.
DR   EMBL; AF209154; AAF36380.1; -; Genomic_DNA.
DR   EMBL; AF209155; AAF36381.1; -; Genomic_DNA.
DR   EMBL; AF209156; AAF36382.1; -; Genomic_DNA.
DR   EMBL; AF210309; AAF63442.1; -; Genomic_DNA.
DR   EMBL; AF210308; AAF63442.1; JOINED; Genomic_DNA.
DR   EMBL; AF210310; AAF63443.1; -; Genomic_DNA.
DR   EMBL; AF240684; AAK76358.1; -; Genomic_DNA.
DR   EMBL; AF240685; AAK76359.1; -; Genomic_DNA.
DR   EMBL; AY270155; AAP30003.1; -; Genomic_DNA.
DR   IPI; IPI00025087; -.
DR   IPI; IPI00375319; -.
DR   PIR; A25224; DNHU53.
DR   RefSeq; NP_000537.3; -.
DR   RefSeq; NP_001119584.1; -.
DR   UniGene; Hs.654481; -.
DR   PDB; 1A1U; NMR; -; A/C=324-358.
DR   PDB; 1AIE; X-ray; 1.50 A; A=326-356.
DR   PDB; 1C26; X-ray; 1.70 A; A=325-356.
DR   PDB; 1DT7; NMR; -; X/Y=367-388.
DR   PDB; 1GZH; X-ray; 2.60 A; A=95-292, C=95-292.
DR   PDB; 1H26; X-ray; 2.24 A; E=376-386.
DR   PDB; 1HS5; NMR; -; A/B=324-357.
DR   PDB; 1JSP; NMR; -; A=367-386.
DR   PDB; 1KZY; X-ray; 2.50 A; A/B=95-289.
DR   PDB; 1MA3; X-ray; 2.00 A; B=372-389.
DR   PDB; 1OLG; NMR; -; A/B/C/D=319-360.
DR   PDB; 1OLH; NMR; -; A/B/C/D=319-360.
DR   PDB; 1PES; NMR; -; A/B/C/D=325-355.
DR   PDB; 1PET; NMR; -; A/B/C/D=325-355.
DR   PDB; 1SAE; NMR; -; A/B/C/D=319-360.
DR   PDB; 1SAF; NMR; -; A/B/C/D=319-360.
DR   PDB; 1SAH; NMR; -; A/B/C/D=319-360.
DR   PDB; 1SAJ; NMR; -; A/B/C/D=319-360.
DR   PDB; 1SAK; NMR; -; A/B/C/D=319-360.
DR   PDB; 1SAL; NMR; -; A/B/C/D=319-360.
DR   PDB; 1TSR; X-ray; 2.20 A; A/B/C=94-312.
DR   PDB; 1TUP; X-ray; 2.20 A; A/B/C=94-312.
DR   PDB; 1UOL; X-ray; 1.90 A; A/B=94-312.
DR   PDB; 1XQH; X-ray; 1.75 A; B/F=369-377.
DR   PDB; 1YC5; X-ray; 1.40 A; B=372-389.
DR   PDB; 1YCQ; X-ray; 2.30 A; B=13-29.
DR   PDB; 1YCR; X-ray; 2.60 A; B=15-29.
DR   PDB; 1YCS; X-ray; 2.20 A; A=94-292.
DR   PDB; 2AC0; X-ray; 1.80 A; A/B/C/D=94-293.
DR   PDB; 2ADY; X-ray; 2.50 A; A/B=94-293.
DR   PDB; 2AHI; X-ray; 1.85 A; A/B/C/D=94-293.
DR   PDB; 2ATA; X-ray; 2.20 A; A/B/C/D=94-293.
DR   PDB; 2B3G; X-ray; 1.60 A; B=33-60.
DR   PDB; 2BIM; X-ray; 1.98 A; A/B=94-312.
DR   PDB; 2BIN; X-ray; 1.90 A; A=94-312.
DR   PDB; 2BIO; X-ray; 1.90 A; A=94-312.
DR   PDB; 2BIP; X-ray; 1.80 A; A=94-312.
DR   PDB; 2BIQ; X-ray; 1.80 A; A=94-312.
DR   PDB; 2F1X; X-ray; 2.30 A; A/B=359-368.
DR   PDB; 2FEJ; NMR; -; A=94-297.
DR   PDB; 2FOJ; X-ray; 1.60 A; B=363-367.
DR   PDB; 2FOO; X-ray; 2.20 A; B=358-363.
DR   PDB; 2GS0; NMR; -; B=20-71.
DR   PDB; 2H1L; X-ray; 3.16 A; M/N/O/P/Q/R/S/T/U/V/W/X=92-292.
DR   PDB; 2H2D; X-ray; 1.70 A; B=372-389.
DR   PDB; 2H2F; X-ray; 2.20 A; B=372-389.
DR   PDB; 2H4F; X-ray; 2.00 A; D=372-389.
DR   PDB; 2H4H; X-ray; 1.99 A; B=372-389.
DR   PDB; 2H4J; X-ray; 2.10 A; D=372-389.
DR   PDB; 2H59; X-ray; 1.90 A; D/E=372-389.
DR   PDB; 2J0Z; NMR; -; A/B/C/D=326-356.
DR   PDB; 2J10; NMR; -; A/B/C/D=326-356.
DR   PDB; 2J11; NMR; -; A/B/C/D=332-356.
DR   PDB; 2J1W; X-ray; 1.80 A; A/B=94-312.
DR   PDB; 2J1X; X-ray; 1.65 A; A/B=94-312.
DR   PDB; 2J1Y; X-ray; 1.69 A; A/B/C/D=94-293.
DR   PDB; 2J1Z; X-ray; 1.80 A; A/B=94-312.
DR   PDB; 2J20; X-ray; 1.80 A; A/B=94-312.
DR   PDB; 2J21; X-ray; 1.60 A; A/B=94-312.
DR   PDB; 2K8F; NMR; -; B=1-39.
DR   PDB; 2OCJ; X-ray; 2.05 A; A/B/C/D=94-312.
DR   PDB; 2PCX; X-ray; 1.54 A; A=94-292.
DR   PDB; 2QVQ; X-ray; 2.00 A; A=94-289.
DR   PDB; 2QXA; X-ray; 1.50 A; A/B/C/D=95-289.
DR   PDB; 2QXB; X-ray; 2.50 A; A/B/C/D=95-289.
DR   PDB; 2QXC; X-ray; 1.85 A; A/B/C/D=95-289.
DR   PDB; 2VUK; X-ray; 1.50 A; A/B=94-312.
DR   PDB; 2WGX; X-ray; 1.75 A; A/B=94-310.
DR   PDB; 2Z5S; X-ray; 2.30 A; P/Q/R=15-29.
DR   PDB; 2Z5T; X-ray; 2.30 A; P/Q/R=15-29.
DR   PDB; 3D05; X-ray; 1.70 A; A=94-293.
DR   PDB; 3D06; X-ray; 1.20 A; A=94-293.
DR   PDB; 3D07; X-ray; 2.20 A; A/B=94-293.
DR   PDB; 3D08; X-ray; 1.40 A; A=94-293.
DR   PDB; 3D09; X-ray; 1.90 A; A=94-293.
DR   PDB; 3D0A; X-ray; 1.80 A; A/B/C/D=94-293.
DR   PDB; 3DAB; X-ray; 1.90 A; B/D/F/H=15-29.
DR   PDB; 3DAC; X-ray; 1.80 A; B/P=17-37.
DR   PDB; 3SAK; NMR; -; A/B/C/D=319-360.
DR   PDBsum; 1A1U; -.
DR   PDBsum; 1AIE; -.
DR   PDBsum; 1C26; -.
DR   PDBsum; 1DT7; -.
DR   PDBsum; 1GZH; -.
DR   PDBsum; 1H26; -.
DR   PDBsum; 1HS5; -.
DR   PDBsum; 1JSP; -.
DR   PDBsum; 1KZY; -.
DR   PDBsum; 1MA3; -.
DR   PDBsum; 1OLG; -.
DR   PDBsum; 1OLH; -.
DR   PDBsum; 1PES; -.
DR   PDBsum; 1PET; -.
DR   PDBsum; 1SAE; -.
DR   PDBsum; 1SAF; -.
DR   PDBsum; 1SAH; -.
DR   PDBsum; 1SAJ; -.
DR   PDBsum; 1SAK; -.
DR   PDBsum; 1SAL; -.
DR   PDBsum; 1TSR; -.
DR   PDBsum; 1TUP; -.
DR   PDBsum; 1UOL; -.
DR   PDBsum; 1XQH; -.
DR   PDBsum; 1YC5; -.
DR   PDBsum; 1YCQ; -.
DR   PDBsum; 1YCR; -.
DR   PDBsum; 1YCS; -.
DR   PDBsum; 2AC0; -.
DR   PDBsum; 2ADY; -.
DR   PDBsum; 2AHI; -.
DR   PDBsum; 2ATA; -.
DR   PDBsum; 2B3G; -.
DR   PDBsum; 2BIM; -.
DR   PDBsum; 2BIN; -.
DR   PDBsum; 2BIO; -.
DR   PDBsum; 2BIP; -.
DR   PDBsum; 2BIQ; -.
DR   PDBsum; 2F1X; -.
DR   PDBsum; 2FEJ; -.
DR   PDBsum; 2FOJ; -.
DR   PDBsum; 2FOO; -.
DR   PDBsum; 2GS0; -.
DR   PDBsum; 2H1L; -.
DR   PDBsum; 2H2D; -.
DR   PDBsum; 2H2F; -.
DR   PDBsum; 2H4F; -.
DR   PDBsum; 2H4H; -.
DR   PDBsum; 2H4J; -.
DR   PDBsum; 2H59; -.
DR   PDBsum; 2J0Z; -.
DR   PDBsum; 2J10; -.
DR   PDBsum; 2J11; -.
DR   PDBsum; 2J1W; -.
DR   PDBsum; 2J1X; -.
DR   PDBsum; 2J1Y; -.
DR   PDBsum; 2J1Z; -.
DR   PDBsum; 2J20; -.
DR   PDBsum; 2J21; -.
DR   PDBsum; 2K8F; -.
DR   PDBsum; 2OCJ; -.
DR   PDBsum; 2PCX; -.
DR   PDBsum; 2QVQ; -.
DR   PDBsum; 2QXA; -.
DR   PDBsum; 2QXB; -.
DR   PDBsum; 2QXC; -.
DR   PDBsum; 2VUK; -.
DR   PDBsum; 2WGX; -.
DR   PDBsum; 2Z5S; -.
DR   PDBsum; 2Z5T; -.
DR   PDBsum; 3D05; -.
DR   PDBsum; 3D06; -.
DR   PDBsum; 3D07; -.
DR   PDBsum; 3D08; -.
DR   PDBsum; 3D09; -.
DR   PDBsum; 3D0A; -.
DR   PDBsum; 3DAB; -.
DR   PDBsum; 3DAC; -.
DR   PDBsum; 3SAK; -.
DR   DisProt; DP00086; -.
DR   DIP; DIP:368N; -.
DR   IntAct; P04637; 137.
DR   STRING; P04637; -.
DR   PhosphoSite; P04637; -.
DR   SWISS-2DPAGE; P04637; -.
DR   Ensembl; ENST00000269305; ENSP00000269305; ENSG00000141510; Homo sapiens.
DR   Ensembl; ENST00000359597; ENSP00000352610; ENSG00000141510; Homo sapiens.
DR   GeneID; 7157; -.
DR   KEGG; hsa:7157; -.
DR   UCSC; uc002gij.2; human.
DR   CTD; 7157; -.
DR   GeneCards; GC17M007512; -.
DR   HGNC; HGNC:11998; TP53.
DR   HPA; CAB002973; -.
DR   MIM; 133239; phenotype.
DR   MIM; 151623; phenotype.
DR   MIM; 161550; phenotype.
DR   MIM; 191170; gene+phenotype.
DR   MIM; 202300; phenotype.
DR   MIM; 211980; phenotype.
DR   MIM; 260500; phenotype.
DR   MIM; 275355; phenotype.
DR   Orphanet; 360; Glioblastoma.
DR   Orphanet; 524; Li-Fraumeni syndrome.
DR   Orphanet; 1333; Pancreatic carcinoma, familial.
DR   Orphanet; 2807; Papilloma of choroid plexus.
DR   PharmGKB; PA36679; -.
DR   HOVERGEN; P04637; -.
DR   Pathway_Interaction_DB; aurora_a_pathway; Aurora A signaling.
DR   Pathway_Interaction_DB; bard1pathway; BARD1 signaling events.
DR   Pathway_Interaction_DB; pi3kciaktpathway; Class I PI3K signaling events mediated by Akt.
DR   Pathway_Interaction_DB; hif1apathway; Hypoxic and oxygen homeostasis regulation of HIF-1-alpha.
DR   Pathway_Interaction_DB; p75ntrpathway; p75(NTR)-mediated signaling.
DR   Pathway_Interaction_DB; hdac_classiii_pathway; Signaling events mediated by HDAC Class III.
DR   Pathway_Interaction_DB; p38alphabetadownstreampathway; Signaling mediated by p38-alpha and p38-beta.
DR   Reactome; REACT_1538; Cell Cycle Checkpoints.
DR   PMAP-CutDB; P04637; -.
DR   ArrayExpress; P04637; -.
DR   Bgee; P04637; -.
DR   GermOnline; ENSG00000141510; Homo sapiens.
DR   GO; GO:0005783; C:endoplasmic reticulum; IEA:UniProtKB-SubCell.
DR   GO; GO:0005626; C:insoluble fraction; IDA:UniProtKB.
DR   GO; GO:0005739; C:mitochondrion; IDA:UniProtKB.
DR   GO; GO:0016363; C:nuclear matrix; IDA:UniProtKB.
DR   GO; GO:0005730; C:nucleolus; IDA:UniProtKB.
DR   GO; GO:0016605; C:PML body; IDA:UniProtKB.
DR   GO; GO:0005524; F:ATP binding; IDA:UniProtKB.
DR   GO; GO:0051087; F:chaperone binding; IPI:UniProtKB.
DR   GO; GO:0003682; F:chromatin binding; IDA:MGI.
DR   GO; GO:0005507; F:copper ion binding; IDA:UniProtKB.
DR   GO; GO:0000739; F:DNA strand annealing activity; IDA:UniProtKB.
DR   GO; GO:0019899; F:enzyme binding; IPI:UniProtKB.
DR   GO; GO:0010843; F:promoter binding; IDA:UniProtKB.
DR   GO; GO:0046982; F:protein heterodimerization activity; IPI:UniProtKB.
DR   GO; GO:0047485; F:protein N-terminus binding; IPI:UniProtKB.
DR   GO; GO:0003700; F:transcription factor activity; IDA:UniProtKB.
DR   GO; GO:0008134; F:transcription factor binding; IPI:UniProtKB.
DR   GO; GO:0008270; F:zinc ion binding; TAS:UniProtKB.
DR   GO; GO:0008635; P:activation of caspase activity by cytochrome c; IDA:UniProtKB.
DR   GO; GO:0006284; P:base-excision repair; TAS:UniProtKB.
DR   GO; GO:0007569; P:cell aging; IMP:UniProtKB.
DR   GO; GO:0007050; P:cell cycle arrest; TAS:UniProtKB.
DR   GO; GO:0042149; P:cellular response to glucose starvation; IDA:MGI.
DR   GO; GO:0042771; P:DNA damage response, signal transduction by...; IDA:MGI.
DR   GO; GO:0006983; P:ER overload response; IDA:MGI.
DR   GO; GO:0044419; P:interspecies interaction between organisms; IEA:UniProtKB-KW.
DR   GO; GO:0030308; P:negative regulation of cell growth; IMP:UniProtKB.
DR   GO; GO:0051097; P:negative regulation of helicase activity; TAS:UniProtKB.
DR   GO; GO:0006289; P:nucleotide-excision repair; IMP:UniProtKB.
DR   GO; GO:0010552; P:positive regulation of specific transcripti...; IDA:UniProtKB.
DR   GO; GO:0051262; P:protein tetramerization; TAS:UniProtKB.
DR   GO; GO:0046902; P:regulation of mitochondrial membrane permea...; TAS:UniProtKB.
DR   GO; GO:0002347; P:response to tumor cell; IEA:InterPro.
DR   GO; GO:0006350; P:transcription; IEA:UniProtKB-KW.
DR   InterPro; IPR012346; p53/RUNT-type_TF_DNA_bd.
DR   InterPro; IPR011615; p53_DNA_bd.
DR   InterPro; IPR010991; p53_tetrameristn.
DR   InterPro; IPR013872; p53_transactivation_domain.
DR   InterPro; IPR002117; p53_tumour_Ag.
DR   InterPro; IPR015551; Trp53.
DR   Gene3D; G3DSA:2.60.40.720; p53_RUNT_DNA_bd; 1.
DR   Gene3D; G3DSA:4.10.170.10; p53_tetrameristn; 1.
DR   PANTHER; PTHR11447; Trp53; 1.
DR   Pfam; PF00870; P53; 1.
DR   Pfam; PF08563; P53_TAD; 1.
DR   Pfam; PF07710; P53_tetramer; 1.
DR   PRINTS; PR00386; P53SUPPRESSR.
DR   ProDom; PD002681; P53; 1.
DR   PROSITE; PS00348; P53; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Activator; Alternative splicing; Apoptosis;
KW   Cell cycle; Complete proteome; Cytoplasm; Disease mutation;
KW   DNA-binding; Endoplasmic reticulum; Glycoprotein;
KW   Host-virus interaction; Isopeptide bond; Li-Fraumeni syndrome;
KW   Metal-binding; Methylation; Nucleus; Phosphoprotein; Polymorphism;
KW   Transcription; Transcription regulation; Tumor suppressor;
KW   Ubl conjugation; Zinc.
FT   CHAIN         1    393       Cellular tumor antigen p53.
FT                                /FTId=PRO_0000185703.
FT   DNA_BIND    102    292
FT   REGION        1     83       Interaction with HRMT1L2.
FT   REGION        1     44       Transcription activation (acidic).
FT   REGION       66    110       Interaction with WWOX.
FT   REGION      100    370       Interaction with HIPK1 (By similarity).
FT   REGION      113    236       Required for interaction with FBXO42.
FT   REGION      116    292       Interaction with AXIN1 (By similarity).
FT   REGION      241    248       Interacts with the 53BP2 SH3 domain.
FT   REGION      256    294       Interaction with E4F1.
FT   REGION      300    393       Interaction with CARM1.
FT   REGION      319    360       Interaction with HIPK2.
FT   REGION      325    356       Oligomerization.
FT   REGION      359    363       Interaction with USP7.
FT   REGION      368    387       Basic (repression of DNA-binding).
FT   MOTIF       305    321       Bipartite nuclear localization signal.
FT   MOTIF       339    350       Nuclear export signal.
FT   MOTIF       370    372       [KR]-[STA]-K motif.
FT   METAL       176    176       Zinc.
FT   METAL       179    179       Zinc.
FT   METAL       238    238       Zinc.
FT   METAL       242    242       Zinc.
FT   MOD_RES       9      9       Phosphoserine; by HIPK4.
FT   MOD_RES      15     15       Phosphoserine; by PRPK.
FT   MOD_RES      18     18       Phosphothreonine; by VRK1.
FT   MOD_RES      46     46       Phosphoserine; by HIPK2.
FT   MOD_RES      55     55       Phosphothreonine; by TAF1.
FT   MOD_RES      99     99       Phosphoserine.
FT   MOD_RES     305    305       N6-acetyllysine.
FT   MOD_RES     315    315       Phosphoserine; by CDC2.
FT   MOD_RES     370    370       N6-methyllysine.
FT   MOD_RES     372    372       N6-methyllysine.
FT   MOD_RES     373    373       N6-acetyllysine.
FT   MOD_RES     382    382       N6-acetyllysine.
FT   MOD_RES     392    392       Phosphoserine; by CK2.
FT   CROSSLNK    291    291       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in ubiquitin).
FT   CROSSLNK    292    292       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in ubiquitin).
FT   CROSSLNK    386    386       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO).
FT   VAR_SEQ     332    341       IRGRERFEMF -> DGTSFQKENC (in isoform 2).
FT                                /FTId=VSP_006535.
FT   VAR_SEQ     342    393       Missing (in isoform 2).
FT                                /FTId=VSP_006536.
FT   VARIANT       5      5       Q -> H (in a sporadic cancer; somatic
FT                                mutation).
FT                                /FTId=VAR_044543.
FT   VARIANT       6      6       S -> L (in a sporadic cancer; somatic
FT                                mutation).
FT                                /FTId=VAR_044544.
FT   VARIANT       7      7       D -> H (in a sporadic cancer; somatic
FT                                mutation).
FT                                /FTId=VAR_005851.
FT   VARIANT       8      8       P -> S (in a sporadic cancer; somatic
FT                                mutation).
FT                                /FTId=VAR_044545.
FT   VARIANT      10     10       V -> I (in a sporadic cancer; somatic
FT                                mutation).
FT                                /FTId=VAR_044546.
FT   VARIANT      11     11       E -> K (in sporadic cancers; somatic
FT                                mutation).
FT                                /FTId=VAR_044547.
FT   VARIANT      11     11       E -> Q (in sporadic cancers; somatic
FT                                mutation).
FT                                /FTId=VAR_044548.
FT   VARIANT      15     15       S -> R (in a sporadic cancer; somatic
FT                                mutation).
FT                                /FTId=VAR_044549.
FT   VARIANT      16     16       Q -> L (in a sporadic cancer; somatic
FT                                mutation).
FT                                /FTId=VAR_044550.
FT   VARIANT      17     17       E -> D (in a sporadic cancer; somatic
FT                                mutation).
FT                                /FTId=VAR_044551.
FT   VARIANT      24     24       K -> N (in a sporadic cancer; somatic
FT                                mutation).
FT                                /FTId=VAR_044552.
FT   VARIANT      28     28       E -> A (in a sporadic cancer; somatic
FT                                mutation).
FT                                /FTId=VAR_044553.
FT   VARIANT      29     30       NN -> KD (in a sporadic cancer; somatic
FT                                mutation).
FT                                /FTId=VAR_047158.
FT   VARIANT      31     31       V -> I (in sporadic cancers; somatic
FT                                mutation).
FT                                /FTId=VAR_044554.
...
FT   VARIANT     389    389       G -> W (in a sporadic cancer; somatic
FT                                mutation).
FT                                /FTId=VAR_045574.
FT   VARIANT     392    392       S -> L (in a sporadic cancer; somatic
FT                                mutation).
FT                                /FTId=VAR_045575.
FT   MUTAGEN      46     46       S->A: Abolishes phosphorylation by HIPK2
FT                                and acetylation of K-382 by CREBBP.
FT   MUTAGEN      46     46       Missing: Alters interaction with WWOX.
FT   MUTAGEN      55     55       T->A: Blocks phosphorylation by TAF1.
FT   MUTAGEN     291    292       KK->RR: Abolishes polyubiquitination by
FT                                MKRN1.
FT   MUTAGEN     359    359       P->D: Abolishes binding to USP7.
FT   MUTAGEN     361    361       G->E: Abolishes binding to USP7.
FT   MUTAGEN     362    362       S->A: Abolishes binding to USP7.
FT   MUTAGEN     370    370       K->R: Induces a decrease in methylation
FT                                by SMYD2.
FT   MUTAGEN     372    372       K->R: Induces a decrease in protein
FT                                stabilization.
FT   MUTAGEN     382    382       K->A: Abolishes acetylation by CREBBP.
FT   MUTAGEN     385    385       F->A: Reduced SUMO1 conjugation.
FT   MUTAGEN     386    386       K->A: Abolishes SUMO1 conjugation, in
FT                                vitro and in vivo.
FT   MUTAGEN     387    387       T->A: No effect SUMO1 conjugation.
FT   MUTAGEN     388    388       E->A: Abolishes SUMO1 conjugation.
FT   HELIX        19     23
FT   HELIX        36     38
FT   HELIX        41     44
FT   HELIX        47     55
FT   TURN        105    108
FT   STRAND      110    112
FT   STRAND      123    127
FT   TURN        128    131
FT   STRAND      132    135
FT   STRAND      141    146
FT   STRAND      156    165
FT   HELIX       166    168
FT   HELIX       177    180
FT   STRAND      187    189
FT   STRAND      194    199
FT   STRAND      204    207
FT   TURN        209    211
FT   STRAND      214    219
FT   STRAND      228    236
FT   TURN        243    248
FT   STRAND      251    258
FT   STRAND      264    274
FT   HELIX       278    287
FT   STRAND      327    334
FT   HELIX       335    354
SQ   SEQUENCE   393 AA;  43712 MW;  AC611E4938C7BC3B CRC64;
     MEEPQSDPSV EPPLSQETFS DLWKLLPENN VLSPLPSQAM DDLMLSPDDI EQWFTEDPGP
     DEAPRMPEAA PRVAPAPAAP TPAAPAPAPS WPLSSSVPSQ KTYQGSYGFR LGFLHSGTAK
     SVTCTYSPAL NKMFCQLAKT CPVQLWVDST PPPGTRVRAM AIYKQSQHMT EVVRRCPHHE
     RCSDSDGLAP PQHLIRVEGN LRVEYLDDRN TFRHSVVVPY EPPEVGSDCT TIHYNYMCNS
     SCMGGMNRRP ILTIITLEDS SGNLLGRNSF EVRVCACPGR DRRTEEENLR KKGEPHHELP
     PGSTKRALPN NTSSSPQPKK KPLDGEYFTL QIRGRERFEM FRELNEALEL KDAQAGKEPG
     GSRAHSSHLK SKKGQSTSRH KKLMFKTEGP DSD
//


	Intentionally not-at-all everything from UniProt is modelled. This format should not substitute the UniProt XML format!
	-->
	<exampleFromUniProtKB>
		<bx:sequenceItem>
			<bx:sequence><!--Computer-readable sequence-->MEEPQSDPSVEPPLSQETFSDLWKLLPENNVLSPLPSQAMDDLMLSPDDIEQWFTEDPGPDEAPRMPEAAPRVAPAPAAPTPAAPAPAPSWPLSSSVPSQKTYQGSYGFRLGFLHSGTAKSVTCTYSPALNKMFCQLAKTCPVQLWVDSTPPPGTRVRAMAIYKQSQHMTEVVRRCPHHERCSDSDGLAPPQHLIRVEGNLRVEYLDDRNTFRHSVVVPYEPPEVGSDCTTIHYNYMCNSSCMGGMNRRPILTIITLEDSSGNLLGRNSFEVRVCACPGRDRRTEEENLRKKGEPHHELPPGSTKRALPNNTSSSPQPKKKPLDGEYFTLQIRGRERFEMFRELNEALELKDAQAGKEPGGSRAHSSHLKSKKGQSTSRHKKLMFKTEGPDSD</bx:sequence>
			<bx:customName>Cellular tumor antigen p53</bx:customName><!--Human-readable name-->
			<bx:freeDescription><!--Human-readable data-->
				alternative names: Tumor suppressor p53, Phosphoprotein p53, Antigen NY-CO-13
				organism: Human (Homo Sapiens, NCBI Taxonomy ID: 9606, lineage: Eukaryota>Metazoa>Chordata>Craniata>Vertebrata>Euteleostomi>Mammalia>Eutheria>Euarchontoglires>Primates>Haplorrhini>Catarrhini>Hominidae>Homo)
				identifier name: P53_HUMAN
				gene: TP53, alternative gene name: P53
				dataset: Swiss-Prot, created: 1987-08-13, last modified: 2009-09-22, entry version: 164
				primary accession: P04637
				secondary accessions: Q15086, Q15087, Q15088, Q16535, Q16807, Q16808, Q16809, Q16810, Q16811, Q16848, Q86UG1, Q8J016, Q99659, Q9BTM4, Q9HAQ8, Q9NP68, Q9NPJ2, Q9NZD0, Q9UBI2, Q9UQ61
				length: 393, mass: 43712, checksum: AC611E4938C7BC3B, sequence version: 3, last modified: 2008-07-22
				annotation project: Human Proteome Initiative (HPI)
				copyright: Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms. Distributed under the Creative Commons Attribution-NoDerivs License.
			</bx:freeDescription>
			<bx:dbReference><!--Computer-readable data-->
				<bx:accession>P04637</bx:accession>
				<bx:uri>http://www.uniprot.org/uniprot/P04637</bx:uri>
				<bx:entryVersion>164</bx:entryVersion>
				<bx:databaseName>UniProt</bx:databaseName>
				<bx:databaseUri>http://www.uniprot.org</bx:databaseUri>
				<bx:date>2010-01-31</bx:date>
				<bx:sequenceVersion>3</bx:sequenceVersion>
				<bx:isoformDescription>P04637-1</bx:isoformDescription>
			</bx:dbReference>
		</bx:sequenceItem>
		<bx:feature>
			<bx:featureType>
				<bx:name>helix</bx:name>
			</bx:featureType>
			<bx:occurence>
				<bx:position>
					<bx:segment>
						<bx:start>19</bx:start>
						<bx:end>23</bx:end>
					</bx:segment>
				</bx:position>
				<bx:evidence>
					<bx:experimental>
						<bx:dbReference>
							<bx:accession>P04637</bx:accession>
						</bx:dbReference>
					</bx:experimental>
				</bx:evidence>
			</bx:occurence>
			<bx:occurence>
				<bx:position>
					<bx:segment>
						<bx:start>36</bx:start>
						<bx:end>38</bx:end>
					</bx:segment>
				</bx:position>
				<bx:evidence>
					<bx:experimental>
						<bx:dbReference>
							<bx:accession>P04637</bx:accession>
						</bx:dbReference>
					</bx:experimental>
				</bx:evidence>
			</bx:occurence>
			<bx:occurence>
				<bx:position>
					<bx:segment>
						<bx:start>41</bx:start>
						<bx:end>44</bx:end>
					</bx:segment>
				</bx:position>
				<bx:evidence>
					<bx:experimental>
						<bx:dbReference>
							<bx:accession>P04637</bx:accession>
						</bx:dbReference>
					</bx:experimental>
				</bx:evidence>
			</bx:occurence>
			<bx:occurence>
				<bx:position>
					<bx:segment>
						<bx:start>47</bx:start>
						<bx:end>55</bx:end>
					</bx:segment>
				</bx:position>
				<bx:evidence>
					<bx:experimental>
						<bx:dbReference>
							<bx:accession>P04637</bx:accession>
						</bx:dbReference>
					</bx:experimental>
				</bx:evidence>
			</bx:occurence>
		</bx:feature>
		<bx:feature>
			<bx:featureType>
				<bx:name>turn</bx:name>
			</bx:featureType>
			<bx:occurence>
				<bx:position>
					<bx:segment>
						<bx:start>105</bx:start>
						<bx:end>108</bx:end>
					</bx:segment>
				</bx:position>
				<bx:evidence>
					<bx:experimental>
						<bx:dbReference>
							<bx:accession>P04637</bx:accession>
						</bx:dbReference>
					</bx:experimental>
				</bx:evidence>
			</bx:occurence>
		</bx:feature>
		<bx:feature>
			<bx:featureType>
				<bx:name>strand</bx:name>
			</bx:featureType>
			<bx:occurence>
				<bx:position>
					<bx:segment>
						<bx:start>110</bx:start>
						<bx:end>112</bx:end>
					</bx:segment>
				</bx:position>
				<bx:evidence>
					<bx:experimental>
						<bx:dbReference>
							<bx:accession>P04637</bx:accession>
						</bx:dbReference>
					</bx:experimental>
				</bx:evidence>
			</bx:occurence>
		</bx:feature>
	</exampleFromUniProtKB>
	
	
	
	<!--====================================================================-->



	<!-- GorIV prediction example

	-->
	<exampleFromGorIV>
		<bx:sequenceItem>
			<bx:sequence>MKKITIYDLAELSGVSASAVSAILNGNWKKRRISAKLAEKVTRIAEEQGYAINRQASMLRSKKSHVIGMIIPKYDNRYFGSIAERFEEMARERGLLPIITCTRRRPELEIEAVKAMLSWQVDWVVATGATNPDKISALCQQAGVPTVNLDLPGSLSPSVISDNYGGAKALTHKILANSARRRGELAPLTFIGGRRATITPASVYAASTMRIASWGLACRRRIFWLPAIRKATLRTACRSGLAARRRCCRGYLLTRRYPWKGLCAGCRRWV</bx:sequence>
			<bx:customName>Test sequence (length 270)</bx:customName>
			<bx:freeDescription>Unknown sequence for GBIO Web Services test ( C Blanchet, 14 jan 2009)</bx:freeDescription>
		</bx:sequenceItem>
		
		<bx:feature>
			<bx:featureType>
				<bx:name>C</bx:name>
			</bx:featureType>
			<bx:occurence>
				<bx:position>
					<bx:point>1</bx:point>
				</bx:position>
				<bx:evidence>
					<bx:predicted>
						<bx:method>GorIV</bx:method>
						<bx:webserviceReference>
							<bx:wsdl>http://bioxsd.org/GorIV.wsdl</bx:wsdl><!--insert IBCP location of wsdl-->
						</bx:webserviceReference>
						<bx:score type="H">0</bx:score>
						<bx:score type="E">0.002</bx:score>
						<bx:score type="C">0.998</bx:score>
						<bx:finding>C</bx:finding><!--Unnecessary. Or could be 'Present/Probable'-->
					</bx:predicted>
				</bx:evidence>
			</bx:occurence>
			<bx:occurence>
				<bx:position>
					<bx:point>2</bx:point>
				</bx:position>
				<bx:evidence>
					<bx:predicted>
						<bx:method>GorIV</bx:method>
						<bx:webserviceReference>
							<bx:wsdl>http://bioxsd.org/GorIV.wsdl</bx:wsdl><!--insert IBCP location of wsdl-->
						</bx:webserviceReference>
						<bx:score type="H">0</bx:score>
						<bx:score type="E">0.015</bx:score>
						<bx:score type="C">0.985</bx:score>
						<bx:finding>C</bx:finding><!--Unnecessary. Or could be 'Present/Probable'-->
					</bx:predicted>
				</bx:evidence>
			</bx:occurence>
			<bx:occurence>
				<bx:position>
					<bx:point>3</bx:point>
				</bx:position>
				<bx:evidence>
					<bx:predicted>
						<bx:method>GorIV</bx:method>
						<bx:webserviceReference>
							<bx:wsdl>http://bioxsd.org/GorIV.wsdl</bx:wsdl><!--insert IBCP location of wsdl-->
						</bx:webserviceReference>
						<bx:score type="H">0</bx:score>
						<bx:score type="E">0.238</bx:score>
						<bx:score type="C">0.762</bx:score>
						<bx:finding>C</bx:finding><!--Unnecessary. Or could be 'Present/Probable'-->
					</bx:predicted>
				</bx:evidence>
			</bx:occurence>
			<!--etc-->
		</bx:feature>
		
		<bx:feature>
			<bx:featureType>
				<bx:name>E</bx:name>
			</bx:featureType>
			<bx:occurence>
				<bx:position>
					<bx:point>4</bx:point>
				</bx:position>
				<bx:evidence>
					<bx:predicted>
						<bx:method>GorIV</bx:method>
						<bx:webserviceReference>
							<bx:wsdl>http://bioxsd.org/GorIV.wsdl</bx:wsdl><!--insert IBCP location of wsdl-->
						</bx:webserviceReference>
						<bx:score type="H">0</bx:score>
						<bx:score type="E">0.698</bx:score>
						<bx:score type="C">0.302</bx:score>
						<bx:finding>E</bx:finding><!--Unnecessary. Or could be 'Present/Probable'-->
					</bx:predicted>
				</bx:evidence>
			</bx:occurence>
			<bx:occurence>
				<bx:position>
					<bx:point>5</bx:point>
				</bx:position>
				<bx:evidence>
					<bx:predicted>
						<bx:method>GorIV</bx:method>
						<bx:webserviceReference>
							<bx:wsdl>http://bioxsd.org/GorIV.wsdl</bx:wsdl><!--insert IBCP location of wsdl-->
						</bx:webserviceReference>
						<bx:score type="H">0</bx:score>
						<bx:score type="E">0.9</bx:score>
						<bx:score type="C">0.1</bx:score>
						<bx:finding>E</bx:finding><!--Unnecessary. Or could be 'Present/Probable'-->
					</bx:predicted>
				</bx:evidence>
			</bx:occurence>
			<bx:occurence>
				<bx:position>
					<bx:point>6</bx:point>
				</bx:position>
				<bx:evidence>
					<bx:predicted>
						<bx:method>GorIV</bx:method>
						<bx:webserviceReference>
							<bx:wsdl>http://bioxsd.org/GorIV.wsdl</bx:wsdl><!--insert IBCP location of wsdl-->
						</bx:webserviceReference>
						<bx:score type="H">0.002</bx:score>
						<bx:score type="E">0.94</bx:score>
						<bx:score type="C">0.058</bx:score>
						<bx:finding>E</bx:finding><!--Unnecessary. Or could be 'Present/Probable'-->
					</bx:predicted>
				</bx:evidence>
			</bx:occurence>
			<bx:occurence>
				<bx:position>
					<bx:point>7</bx:point>
				</bx:position>
				<bx:evidence>
					<bx:predicted>
						<bx:method>GorIV</bx:method>
						<bx:webserviceReference>
							<bx:wsdl>http://bioxsd.org/GorIV.wsdl</bx:wsdl><!--insert IBCP location of wsdl-->
						</bx:webserviceReference>
						<bx:score type="H">0.013</bx:score>
						<bx:score type="E">0.763</bx:score>
						<bx:score type="C">0.224</bx:score>
						<bx:finding>E</bx:finding><!--Unnecessary. Or could be 'Present/Probable'-->
					</bx:predicted>
				</bx:evidence>
			</bx:occurence>
			<bx:occurence>
				<bx:position>
					<bx:point>8</bx:point>
				</bx:position>
				<bx:evidence>
					<bx:predicted>
						<bx:method>GorIV</bx:method>
						<bx:webserviceReference>
							<bx:wsdl>http://bioxsd.org/GorIV.wsdl</bx:wsdl><!--insert IBCP location of wsdl-->
						</bx:webserviceReference>
						<bx:score type="H">0.079</bx:score>
						<bx:score type="E">0.527</bx:score>
						<bx:score type="C">0.394</bx:score>
						<bx:finding>E</bx:finding><!--Unnecessary. Or could be 'Present/Probable'-->
					</bx:predicted>
				</bx:evidence>
			</bx:occurence>
			<!--etc-->
		</bx:feature>
		
		<bx:feature>
			<bx:featureType>
				<bx:name>H</bx:name>
			</bx:featureType>
			<bx:occurence>
				<bx:position>
					<bx:point>9</bx:point>
				</bx:position>
				<bx:evidence>
					<bx:predicted>
						<bx:method>GorIV</bx:method>
						<bx:webserviceReference>
							<bx:wsdl>http://bioxsd.org/GorIV.wsdl</bx:wsdl><!--insert IBCP location of wsdl-->
						</bx:webserviceReference>
						<bx:score type="H">0.559</bx:score>
						<bx:score type="E">0.197</bx:score>
						<bx:score type="C">0.224</bx:score>
						<bx:finding>H</bx:finding><!--Unnecessary. Or could be 'Present/Probable'-->
					</bx:predicted>
				</bx:evidence>
			</bx:occurence>
			<bx:occurence>
				<bx:position>
					<bx:point>10</bx:point>
				</bx:position>
				<bx:evidence>
					<bx:predicted>
						<bx:method>GorIV</bx:method>
						<bx:webserviceReference>
							<bx:wsdl>http://bioxsd.org/GorIV.wsdl</bx:wsdl><!--insert IBCP location of wsdl-->
						</bx:webserviceReference>
						<bx:score type="H">0.506</bx:score>
						<bx:score type="E">0.203</bx:score>
						<bx:score type="C">0.292</bx:score>
						<bx:finding>H</bx:finding><!--Unnecessary. Or could be 'Present/Probable'-->
					</bx:predicted>
				</bx:evidence>
			</bx:occurence>
			<bx:occurence>
				<bx:position>
					<bx:point>11</bx:point>
				</bx:position>
				<bx:evidence>
					<bx:predicted>
						<bx:method>GorIV</bx:method>
						<bx:webserviceReference>
							<bx:wsdl>http://bioxsd.org/GorIV.wsdl</bx:wsdl><!--insert IBCP location of wsdl-->
						</bx:webserviceReference>
						<bx:score type="H">0.581</bx:score>
						<bx:score type="E">0.153</bx:score>
						<bx:score type="C">0.265</bx:score>
						<bx:finding>H</bx:finding><!--Unnecessary. Or could be 'Present/Probable'-->
					</bx:predicted>
				</bx:evidence>
			</bx:occurence>
			<bx:occurence>
				<bx:position>
					<bx:point>12</bx:point>
				</bx:position>
				<bx:evidence>
					<bx:predicted>
						<bx:method>GorIV</bx:method>
						<bx:webserviceReference>
							<bx:wsdl>http://bioxsd.org/GorIV.wsdl</bx:wsdl><!--insert IBCP location of wsdl-->
						</bx:webserviceReference>
						<bx:score type="H">0.498</bx:score>
						<bx:score type="E">0.087</bx:score>
						<bx:score type="C">0.415</bx:score>
						<bx:finding>H</bx:finding><!--Unnecessary. Or could be 'Present/Probable'-->
					</bx:predicted>
				</bx:evidence>
			</bx:occurence>
			<!--etc-->
		</bx:feature>
		
		<!--etc-->
	</exampleFromGorIV>



	<!--====================================================================-->


	<!-- set of sequences

	-->
	<listOfSequences>		
		<sequenceRecord>
			<bx:sequence>MHTHEYITMIMHKFVNRSEELEKLRAYLEKRSLIIVYGRRRVGKTRLIIEALKDTPHVYHLCKEEEPRETLVSLSKKLYHATGDAQFLESPPSSFDELFELLGGIGITLVLDEFPLLVKNYPRILGLLQEYWDFGEGGSVVLCGSSVSMMKGLTDYGSPIHGRRTISVKVKPLEFRHVGEFFPGYSPEELVRAYGVLDGIPEYLLRFDPSQSVEENVIREFFGRGYLYEEAELLLRYELRDLSTYNTILEAIAAGYTSFNEIKTKTGMDGSKLSRYLSTLEELELVKREYPVLGAAKRRRKGARYGLSDNYFAFYYSFVYPFKEEIELGLLDVPLENFRRKFNRYLGRV</bx:sequence>
			<bx:customName>O05173_9EURY (O05173) Hypothetical protein</bx:customName>
			<bx:dbReference>
				<bx:accession>O05173</bx:accession>
				<bx:databaseName>UniProt</bx:databaseName>
			</bx:dbReference>
		</sequenceRecord>
		<sequenceRecord>
			<bx:sequence>MGSHMSVKEKLTLTQLILIRLSNRGCQTLEELQTFTNAKREVLLVILTRMHKKGLIYRKWRRFGGRKFREYCLKSREEIVG</bx:sequence>
			<bx:customName>O05472_SULIS (O05472) ORF81</bx:customName>
			<bx:dbReference>
				<bx:accession>O05472</bx:accession>
			</bx:dbReference>
		</sequenceRecord>
		<sequenceRecord>
			<bx:sequence>MDIIEIIKLYNPKFSLNKKNVFMIPVEYLDEVQKLADSYNAKTEVLKRIRKYAFVKWTPCEEVKELS</bx:sequence>
			<bx:customName>O05473_SULIS (O05473) ORF67</bx:customName>
		</sequenceRecord>
		<sequenceRecord>
			<bx:sequence>MLPIFGGKKEETWKGKRRGKIITIQLPDELYEEINMVCERYGIKKSEFIRNAVIEKLIQMQSKNT</bx:sequence>
			<bx:customName>O05474_SULIS (O05474) ORF65</bx:customName>
		</sequenceRecord>
		<sequenceRecord>
			<bx:sequence>MNADEIFSNLEEILNYNSLVFINRKNIEVVWAIRSDTDTVQGFVRVDNKVFPFKAWVEFEGELRVQIGNLIHFIIDSKTVKAIQRESE</bx:sequence>
			<bx:customName>O05475_SULIS (O05475) ORF89 (length 88)</bx:customName>
		</sequenceRecord>
		<sequenceRecord>
			<bx:sequence>MVSTKPNVHIRLREEERKLLKEIAQKYDISESDVVKIALKKLARELGMDNSP</bx:sequence>
			<bx:customName>O05476_SULIS (O05476) CopG</bx:customName>
		</sequenceRecord>
		<sequenceRecord>
			<bx:sequence>MSNFSNQDKKRFAEWFIEQGFAIFPIDPQSKKPVISNWQKYSHEPLTDEEKKRFLEQIEKGYNYAVPGGQQNLVILDFESKELLEKWISKSALDELCRKTLCVNTPHGGIHVYVQADNIPEHKFNPAFTLNGKGIADLQSYNSYVLGVGSCINHKFCDSDKCKWRGQNHTTCYSLYNNNELKIGRADLKGLLKFLAEKGKELGIELSSNARAWLEGEKEETDVEKDLEKLKKELSRFNKFKGKTIEAIRSEVCQSIKKSLENVKSDKAKTMLNTAFQVVCQGKSYGEIQLDRSRGDWHVLKVLLSHGVTDVEVLKQLLPQDSKVFAPKWDRYFLHTLMKAWNEVKPFLQIIKNAKNKKTKELKQELAEVLSQYIIRKYHIVTFIQKHSNGESIIGIFRWNRKKGIYEPIDETLKKIIRHEIMRVIETFPKSEDEKSPMFYEVRNELVKLVYDEIRDLTLTEYDDDNTPLRIAFENCTLEWTSDKFKLIPADKRTEEHYAFHYVPHKIRVEVFNNTPYQVPELEELARKLCPKSLNAFKQWVGEKWVTLFEIIGYTLYPATKFKLAFMLLGPRDSGKSTFLQLLKRILGKQNTVSIRLRELFDPNNRFVAGFLFHKLVNLTAETKEYTIEDIDRFKTLTGGDQITSDVKFKGPITFTPYAKLIIASNKLPDIRDKNDTAFWRRWLIIEFPNQFPNDDNWFRQTFTEEEIEGILTVSILAFARVMSRGQFDYQQTPEEVRDLWLYNIDSVWSFVRTYEKKGFITVDPRNADLWVPRIELYKLYKDYCMDNGFPGVSLKTFANKLNKYFGITSMKKYFGKDPNGKEIRRRCFVGITINYGALELEKLGKPQDITPSVPQEIRRFEECLGFSVGNIAYQLSTRTVVREEELLKLFKDQHGVVKKVEECLRELNFVDNGDGTFRKPTPEELYKDYKCTTIWYTSQYNELKGKTVKVKDLDPDFLMCLKKFGQMEQVDDETIRIK</bx:sequence>
			<bx:customName>O05477_SULIS (O05477) Helicase-like protein (length 979)</bx:customName>
		</sequenceRecord>		
	</listOfSequences>



	<!--====================================================================-->



	<!-- multiple sequence alignment example

	-->
	<multipleSequenceAlignment>
		<bx:alignedSequence>
			<bx:sequenceItem>
				<bx:sequence>MNADEIFSNLEEILNYNSLVFINRKNIEVVWAIRSDTDTVQGFVRVDNKVFPFKAWVEFEGELRVQIGNLIHFIIDSKTVKAIQRESE</bx:sequence>
				<bx:customName>O05475_SULIS (O05475) ORF89 (length 88)</bx:customName>
			</bx:sequenceItem>
			<bx:gap start="-1" len="220"/><!--right coordinates-->
			<bx:gap start="15" len="1"/>
			<bx:gap start="17" len="6"/>
			<bx:gap start="23" len="7"/>
			<bx:gap start="30" len="33"/>
			<bx:gap start="34" len="8"/>
			<bx:gap start="45" len="1"/>
			<bx:gap start="52" len="11"/>
			<bx:gap start="61" len="14"/>
			<bx:gap start="71" len="1"/>
			<bx:gap start="77" len="1"/>
			<bx:gap start="88" len="590"/><!--unnecessary: end-->
		</bx:alignedSequence>
			
		<bx:alignedSequence>
			<bx:sequenceItem>
				<bx:sequence>MSNFSNQDKKRFAEWFIEQGFAIFPIDPQSKKPVISNWQKYSHEPLTDEEKKRFLEQIEKGYNYAVPGGQQNLVILDFESKELLEKWISKSALDELCRKTLCVNTPHGGIHVYVQADNIPEHKFNPAFTLNGKGIADLQSYNSYVLGVGSCINHKFCDSDKCKWRGQNHTTCYSLYNNNELKIGRADLKGLLKFLAEKGKELGIELSSNARAWLEGEKEETDVEKDLEKLKKELSRFNKFKGKTIEAIRSEVCQSIKKSLENVKSDKAKTMLNTAFQVVCQGKSYGEIQLDRSRGDWHVLKVLLSHGVTDVEVLKQLLPQDSKVFAPKWDRYFLHTLMKAWNEVKPFLQIIKNAKNKKTKELKQELAEVLSQYIIRKYHIVTFIQKHSNGESIIGIFRWNRKKGIYEPIDETLKKIIRHEIMRVIETFPKSEDEKSPMFYEVRNELVKLVYDEIRDLTLTEYDDDNTPLRIAFENCTLEWTSDKFKLIPADKRTEEHYAFHYVPHKIRVEVFNNTPYQVPELEELARKLCPKSLNAFKQWVGEKWVTLFEIIGYTLYPATKFKLAFMLLGPRDSGKSTFLQLLKRILGKQNTVSIRLRELFDPNNRFVAGFLFHKLVNLTAETKEYTIEDIDRFKTLTGGDQITSDVKFKGPITFTPYAKLIIASNKLPDIRDKNDTAFWRRWLIIEFPNQFPNDDNWFRQTFTEEEIEGILTVSILAFARVMSRGQFDYQQTPEEVRDLWLYNIDSVWSFVRTYEKKGFITVDPRNADLWVPRIELYKLYKDYCMDNGFPGVSLKTFANKLNKYFGITSMKKYFGKDPNGKEIRRRCFVGITINYGALELEKLGKPQDITPSVPQEIRRFEECLGFSVGNIAYQLSTRTVVREEELLKLFKDQHGVVKKVEECLRELNFVDNGDGTFRKPTPEELYKDYKCTTIWYTSQYNELKGKTVKVKDLDPDFLMCLKKFGQMEQVDDETIRIK</bx:sequence>
				<bx:customName>O05477_SULIS (O05477) Helicase-like protein (length 979)</bx:customName>
			</bx:sequenceItem>
			<bx:gap start="242" len="1"/><!--right coordinates-->
			<bx:gap start="319" len="1"/>
		</bx:alignedSequence>
			
		<bx:alignedSequence>
			<bx:sequenceItem>
				<bx:sequence>MGSHMSVKEKLTLTQLILIRLSNRGCQTLEELQTFTNAKREVLLVILTRMHKKGLIYRKWRRFGGRKFREYCLKSREEIVG</bx:sequence>
				<bx:customName>O05472_SULIS (O05472) ORF81</bx:customName>
				<bx:dbReference>
					<bx:accession>O05472</bx:accession>
				</bx:dbReference>
			</bx:sequenceItem>
			<bx:gap start="-1" len="220"/><!--these are not right, just arbitrary gaps-->
			<bx:gap start="15" len="1"/>
			<bx:gap start="17" len="6"/>
			<bx:gap start="23" len="7"/>
			<bx:gap start="30" len="33"/>
			<bx:gap start="34" len="8"/>
		</bx:alignedSequence>
			
		<bx:alignedSequence>
			<bx:sequenceItem>
				<bx:sequence>MHTHEYITMIMHKFVNRSEELEKLRAYLEKRSLIIVYGRRRVGKTRLIIEALKDTPHVYHLCKEEEPRETLVSLSKKLYHATGDAQFLESPPSSFDELFELLGGIGITLVLDEFPLLVKNYPRILGLLQEYWDFGEGGSVVLCGSSVSMMKGLTDYGSPIHGRRTISVKVKPLEFRHVGEFFPGYSPEELVRAYGVLDGIPEYLLRFDPSQSVEENVIREFFGRGYLYEEAELLLRYELRDLSTYNTILEAIAAGYTSFNEIKTKTGMDGSKLSRYLSTLEELELVKREYPVLGAAKRRRKGARYGLSDNYFAFYYSFVYPFKEEIELGLLDVPLENFRRKFNRYLGRV</bx:sequence>
				<bx:customName>O05173_9EURY (O05173) Hypothetical protein</bx:customName>
				<bx:dbReference>
					<bx:accession>O05173</bx:accession>
					<bx:databaseName>UniProt</bx:databaseName>
				</bx:dbReference>
			</bx:sequenceItem>
			<bx:gap start="23" len="7"/><!--these are not right, just arbitrary gaps-->
			<bx:gap start="30" len="33"/>
			<bx:gap start="34" len="8"/>
			<bx:gap start="45" len="1"/>
		</bx:alignedSequence>
			
		<bx:alignedSequence>
			<bx:sequenceItem>
				<bx:sequence>MVSTKPNVHIRLREEERKLLKEIAQKYDISESDVVKIALKKLARELGMDNSP</bx:sequence>
				<bx:customName>O05476_SULIS (O05476) CopG</bx:customName>
			</bx:sequenceItem>
			<bx:gap start="-1" len="220"/><!--these are not right, just arbitrary gaps-->
			<bx:gap start="15" len="1"/>
			<bx:gap start="17" len="6"/>
			<bx:gap start="23" len="7"/>
			<bx:gap start="30" len="33"/>
			<bx:gap start="34" len="8"/>
		</bx:alignedSequence>
			
		<bx:alignedSequence>
			<bx:sequenceItem>
				<bx:sequence>MDIIEIIKLYNPKFSLNKKNVFMIPVEYLDEVQKLADSYNAKTEVLKRIRKYAFVKWTPCEEVKELS</bx:sequence>
				<bx:customName>O05473_SULIS (O05473) ORF67</bx:customName>
			</bx:sequenceItem>
			<bx:gap start="-1" len="220"/><!--these are not right, just arbitrary gaps-->
			<bx:gap start="15" len="1"/>
			<bx:gap start="17" len="6"/>
			<bx:gap start="23" len="7"/>
			<bx:gap start="30" len="33"/>
			<bx:gap start="34" len="8"/>
		</bx:alignedSequence>
			
		<bx:alignedSequence>
			<bx:sequenceItem>
				<bx:sequence>MLPIFGGKKEETWKGKRRGKIITIQLPDELYEEINMVCERYGIKKSEFIRNAVIEKLIQMQSKNT</bx:sequence>
				<bx:customName>O05474_SULIS (O05474) ORF65</bx:customName>
			</bx:sequenceItem>
			<bx:gap start="-1" len="220"/><!--these are not right, just arbitrary gaps-->
			<bx:gap start="15" len="1"/>
			<bx:gap start="17" len="6"/>
			<bx:gap start="23" len="7"/>
			<bx:gap start="30" len="33"/>
			<bx:gap start="34" len="8"/>
		</bx:alignedSequence>
	</multipleSequenceAlignment>



	<!--====================================================================-->



</bxExamples>

